TDAC and TDACU Related Headlines
Go Back- ProLogium files F-4 with SEC ahead of planned SPAC merger
- TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger
- TDAC shareholders vote to extend SPAC, keeping $156.8M in trust
- TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote
TDAC and TDACU Related Press Releases
Go Back- TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger
- TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote
TDAC and TDACU Related SEC Filings
Go Back- Form 425 Translational Developmen Filed by: Prologium Holding Inc.
- Form 425 Translational Developmen Filed by: Translational Development Acquisition Corp.
- Form 8-K Translational Developmen For: Jul 27
- Form SCHEDULE 13G/A Translational Developmen Filed by: WOLVERINE ASSET MANAGEMENT LLC
- Form 8-K Translational Developmen For: Jul 06
- Form 425 Translational Developmen Filed by: Prologium Holding Inc.
- Form DEFA14A Translational Developmen
- Form 425 Translational Developmen Filed by: Translational Development Acquisition Corp.
- Form 8-K Translational Developmen For: Jun 22
- Form 425 Translational Developmen Filed by: Prologium Holding Inc.
- Form 425 Translational Developmen Filed by: Prologium Holding Inc.
- Form 8-K Translational Developmen For: Jun 17
- Form 425 Translational Developmen Filed by: Prologium Holding Inc.
- Form 8-K Translational Developmen For: Jun 12
- Form 425 Translational Developmen Filed by: Prologium Holding Inc.
- Form 425 Translational Developmen Filed by: Prologium Holding Inc.
- Form SCHEDULE 13G Translational Developmen Filed by: Linden Capital L.P.
- Form DEFA14A Translational Developmen
- Form DEF 14A Translational Developmen For: Jun 17
- Form 425 Translational Developmen Filed by: Translational Development Acquisition Corp.
- Form 8-K Translational Developmen For: May 27
- Form 10-Q Translational Developmen For: Mar 31
- Form SCHEDULE 13G Translational Developmen Filed by: GOLDMAN SACHS GROUP INC
- Form 10-K/A Translational Developmen For: Dec 31
- Form 10-K/A Translational Developmen For: Dec 31
- Form PRE 14A Translational Developmen For: Jun 17
- Form 10-K Translational Developmen For: Dec 31

